| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
| 05/26/2011 | US20110126298 Transgenic Mice Over-Expressing Receptor For Advanced Glycation Endproduct (RAGE) In Brain And Uses Thereof |
| 05/26/2011 | US20110125530 Central server system for collecting patient health condition management data |
| 05/26/2011 | US20110125414 Method for operating a gas sensor |
| 05/26/2011 | US20110125413 Device and system to reconstruct travel history of an individual |
| 05/26/2011 | US20110125411 Uniquemer Algorithm for Identification of Conserved and Unique Subsequences |
| 05/26/2011 | US20110125410 Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| 05/26/2011 | US20110125409 Measuring and analyzing multi-dimensional sensory information for identification purposes |
| 05/26/2011 | US20110125408 Thermoelectric biosensor for analytes in a gas |
| 05/26/2011 | US20110124639 3 beta-hydroxysteroid dehydrogenase inhibitors |
| 05/26/2011 | US20110124560 Foxp3 oligomerization and intermolecular interactions |
| 05/26/2011 | US20110124530 Pseudo-tissues and uses thereof |
| 05/26/2011 | US20110124519 Method of assessing kidney function in a human subject |
| 05/26/2011 | US20110124516 Polymer Particles and Uses Thereof |
| 05/26/2011 | US20110124513 Profiles of volatile hydrocarbons, markers of degradation/ageing of cellulosic material and markers of pathology |
| 05/26/2011 | US20110124503 Novel herbicide resistance genes |
| 05/26/2011 | US20110124185 Graded core/shell semiconductor nanorods and nanorod barcodes |
| 05/26/2011 | US20110124132 Centrifugal micro-fluidic device and method for detecting target in fluid sample |
| 05/26/2011 | US20110124131 Method for preparing metal nanoparticle using metal binding protein |
| 05/26/2011 | US20110124130 Device and method for analysis of samples with depletion of analyte content |
| 05/26/2011 | US20110124129 Methods and systems to control fluid flow in accordance with a predetermined sequence |
| 05/26/2011 | US20110124128 Centrifugal Force Based Microfluidic System And Method For The Automated Analysis of Samples |
| 05/26/2011 | US20110124127 Methods of quantification for lateral flow devices |
| 05/26/2011 | US20110124126 Detection of an analyte in aqueous media |
| 05/26/2011 | US20110124125 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 05/26/2011 | US20110124124 Enhanced detection sensitivity with piezoelectric microcantilever sensors |
| 05/26/2011 | US20110124123 Method for examining wt1-related disease |
| 05/26/2011 | US20110124122 Biomarkers and assays for myocardial infarction |
| 05/26/2011 | US20110124121 Methods for predicting weight loss success |
| 05/26/2011 | US20110124120 Assay for evaluating affinity and specificity of ligand-albumin binding |
| 05/26/2011 | US20110124119 Methods For Assessing Modified LDL Immune Complexes in Subjects Having or at Risk of Coronary Artery Disease |
| 05/26/2011 | US20110124118 Microfluidic structure for detecting biomolecule and microfluidic device comprising the same |
| 05/26/2011 | US20110124116 Multi-array, multi-specific electrochemiluminescence testing |
| 05/26/2011 | US20110124114 Assays |
| 05/26/2011 | US20110124113 Methods and devices for detecting unsaturated compounds |
| 05/26/2011 | US20110124112 Use of Carbon Nanomaterials as a Filtration Material Impervious to Ozone |
| 05/26/2011 | US20110124111 Low-volume sequencing system and method of use |
| 05/26/2011 | US20110124110 Systems and methods for breast cancer detection and risk assessment |
| 05/26/2011 | US20110124020 Methods for Detecting Antibodies |
| 05/26/2011 | US20110124019 Method of using carbonic anhydrase to detect hemolysis |
| 05/26/2011 | US20110124018 Detection of pathogenic polypeptides using an epitope protection assay |
| 05/26/2011 | US20110124017 Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases |
| 05/26/2011 | US20110124016 Diagnosis and Treatment of Malignant Neoplasms |
| 05/26/2011 | US20110124015 Aptamer-based methods for identifying cellular biomarkers |
| 05/26/2011 | US20110124014 Tissue Differentiation Method Based on Surface Enhanced Raman Scattering |
| 05/26/2011 | US20110124013 Galactose-alpha-1,3-galactose-macromolecule conjugates and methods employing same |
| 05/26/2011 | US20110124012 Assays for human nt-pro b-type natriuretic peptide, human pro b-type natriuretic peptide and human b-type natriuretic peptide |
| 05/26/2011 | US20110124011 Method for determining sumoylation |
| 05/26/2011 | US20110124010 Diagnostic method |
| 05/26/2011 | US20110124009 Composition, kit and method for assaying neuropathy |
| 05/26/2011 | US20110124008 NOVEL Au/Ag CORE-SHELL COMPOSITE USEFUL FOR BIOSENSOR |
| 05/26/2011 | US20110124007 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer |
| 05/26/2011 | US20110124006 Method for screening of therapeutic agent for cancer |
| 05/26/2011 | US20110124004 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer |
| 05/26/2011 | US20110124003 Cytological Methods for Detecting Cancer |
| 05/26/2011 | US20110124001 Compositions For Use In Detection Of Multiple Analytes |
| 05/26/2011 | US20110123999 Novel Polymorphism in Bovine Prion Protein Gene Sequence |
| 05/26/2011 | US20110123998 Materials and Methods for Treatment of Cancer |
| 05/26/2011 | US20110123997 Molecular diagnosis and classification of malignant melanoma |
| 05/26/2011 | US20110123996 Methods and compositions to evaluate antibody treatment response |
| 05/26/2011 | US20110123987 Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/26/2011 | US20110123986 Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/26/2011 | US20110123976 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR |
| 05/26/2011 | US20110123689 Oven and method of operating the same |
| 05/26/2011 | US20110123570 Actinobacillus suis antigens |
| 05/26/2011 | US20110123567 Recombinant rift valley fever (rvf) viruses and methods of use |
| 05/26/2011 | US20110123565 Structural Proteins of Fish Pancreatic Disease Virus and Uses Thereof |
| 05/26/2011 | US20110123558 Peptide with Reduced Dimer Formation |
| 05/26/2011 | US20110123557 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 |
| 05/26/2011 | US20110123556 Immunogen prioritization for vaccine design |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123551 Hvem/btla, hvem/cd 160 and hvem/gd cis complexes and methods of use |
| 05/26/2011 | US20110123550 Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human pd-1 antibody on cancers |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123537 Binding epitopes for g250 antibody |
| 05/26/2011 | US20110123533 Using EGFRvIII to Identify and Target Cancer Stem Cells |
| 05/26/2011 | US20110123530 Compositions and methods for treating and diagnosing asthma |
| 05/26/2011 | US20110123527 Method of generating single vl domain antibodies in transgenic animals |
| 05/26/2011 | US20110123502 Method for obtaining treg-cells |
| 05/26/2011 | US20110123488 Method of Treatment for Cancers Associated with Elevated HER2 Levels |
| 05/26/2011 | US20110123484 Methods and compositions for treating fus1 related disorders |
| 05/26/2011 | US20110123454 Method for modulating appetite |
| 05/26/2011 | US20110123447 Method of providing human tumor-specific antibodies |
| 05/26/2011 | US20110123443 Pancreatic beta-cell mass biomarker |
| 05/26/2011 | US20110123442 Tumor specific antibodies and uses therefor |
| 05/26/2011 | US20110123400 Apparatus for detecting metal concentration in an atmosphere |
| 05/26/2011 | US20110123398 Three-dimensional microfluidic devices |
| 05/26/2011 | US20110122397 Fugitive emission flux measurement |
| 05/26/2011 | US20110121165 Multi-element screening of trace elements |
| 05/26/2011 | US20110120865 Analyte Sensors Comprising High-Boiling Point Solvents |
| 05/26/2011 | US20110120864 Cellular electrophysiology sensor chip and cellular electrophysiology sensor using the chip, and method of manufacturing cellular electrophysiology sensor chip |
| 05/26/2011 | US20110120239 Dissolution test vessel with integral centering |
| 05/26/2011 | US20110120236 Sample collector and test device |
| 05/26/2011 | US20110120206 Methods of calibrating a sensor in a patient monitoring system |
| 05/26/2011 | DE202011002871U1 Tisch zur Auswertung einer Thrombozytenaggregation auf einem Objektträger mit einer intravaskulären Aktivität der Thrombozyte Table for evaluation of platelet aggregation on a slide with an intravascular activity of platelets |
| 05/26/2011 | DE19542225B4 Verfahren und Vorrichtung zur Bestimmung von rheologischen und mechanischen Stoffkenngrößen Method and device for determination of rheological and mechanical characteristics of materials |
| 05/26/2011 | DE102009054316A1 Verfahren zur Bestimmung des bei der Verbrennung von Brenngas emittierten Kohlenstoffdioxids A method for determining the emitted during the combustion of fuel gas carbon dioxide |